CD200 Limits Monopoiesis and Monocyte Recruitment in Atherosclerosis (original) (raw)

Abstract

Rationale: Inflammation is a basic component of the pathogenesis of atherosclerosis. CD200 is an immune checkpoint known to control macrophage activation. CD200 recently emerged in the Framingham Heart Study and 2 other cohorts as being potentially relevant in cardiovascular disease. The role of this pathway in cardiovascular disease is unknown. Objective: We sought to examine the role of CD200 in atherosclerosis. Methods and Results: Using hypercholesterolemic apolipoprotein-E deficient mice, we demonstrate that whole-body CD200 deficiency augments atherosclerotic lesion formation and vulnerability. Administration of a CD200-Fusion protein reduces neointima formation. Our data show that the CD200-CD200R pathway restrains activation of CD200R+ lesional macrophages, their production of CCR2 ligands, and monocyte recruitment in vitro and in vivo in an air pouch model. Loss of CD200 leads to an excessive accumulation of classical Ly6C hi monocytes and CCR2 + macrophages within the athe...

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (45)

  1. The Kennedy Trustees, and the Novo Nordisk Foundation (Grant number NNF15CC0018346). REFERENCES
  2. Kusters PJH, Lutgens E, Seijkens TTP. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis. Cardiovasc Res. 2018;114:368-377. doi: 10.1093/cvr/cvx248
  3. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000;290:1768-1771. doi: 10.1126/science.290.5497.1768
  4. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T, et al. Char- acterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol. 2003;171:3034-3046. doi: 10.4049/jimmunol.171.6.3034
  5. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, Brown MH, Barclay AN. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity. 2000;13:233-242. doi: 10.1016/s1074-7613(00)00023-6
  6. Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, Edwards L, Gwyer E, Sedgwick JD, Barclay AN, Hussell T. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol. 2008;9:1074-1083. doi: 10.1038/ni.1637
  7. Huan T, Zhang B, Wang Z, Joehanes R, Zhu J, Johnson AD, Ying S, Munson PJ, Raghavachari N, Wang R, et al; Coronary ARteryDIsease Genome wide Replication and Meta-analysis (CARDIoGRAM) Consor- tium, International Consortium for Blood Pressure GWAS (ICBP). A sys- tems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler Thromb Vasc Biol. 2013;33:1427-1434. doi: 10.1161/ATVBAHA.112.300112
  8. Wong KK, Brenneman F, Chesney A, Spaner DE, Gorczynski RM. Sol- uble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice. Cancer Res. 2012;72:4931-4943. doi: 10.1158/0008-5472.CAN-12-1390
  9. Ganz P, Heidecker B, Hveem K, Jonasson C, Kato S, Segal MR, Sterling DG, Williams SA. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart dis- ease. JAMA. 2016;315:2532-2541. doi: 10.1001/jama.2016.5951
  10. Cole JE, Astola N, Cribbs AP, Goddard ME, Park I, Green P, Davies AH, Williams RO, Feldmann M, Monaco C. Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proc Natl Acad Sci USA. 2015;112:13033-13038. doi: 10.1073/pnas.1517820112
  11. Cole JE, Park I, Ahern DJ, Kassiteridi C, Danso Abeam D, Goddard ME, Green P, Maffia P, Monaco C. Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity. Cardio- vasc Res. 2018;114:1360-1371. doi: 10.1093/cvr/cvy109
  12. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117:185-194. doi: 10.1172/JCI28549
  13. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195-205. doi: 10.1172/JCI29950
  14. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 2008;117:1649-1657. doi: 10.1161/CIRCULATIONAHA.107.745091
  15. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007;117:902-909. doi: 10.1172/JCI29919
  16. Weiss M, Byrne AJ, Blazek K, Saliba DG, Pease JE, Perocheau D, Feldmann M, Udalova IA. IRF5 controls both acute and chronic inflammation. Proc Natl Acad Sci USA. 2015;112:11001-11006. doi: 10.1073/pnas.1506254112
  17. Seneviratne AN, Edsfeldt A, Cole JE, Kassiteridi C, Swart M, Park I, Green P, Khoyratty T, Saliba D, Goddard ME, et al. Interferon regula- tory factor 5 controls necrotic core formation in atherosclerotic lesions by impairing efferocytosis. Circulation. 2017;136:1140-1154. doi: 10.1161/CIRCULATIONAHA.117.027844
  18. Hettinger J, Richards DM, Hansson J, Barra MM, Joschko AC, Krijgsveld J, Feuerer M. Origin of monocytes and macrophages in a committed progeni- tor. Nat Immunol. 2013;14:821-830. doi: 10.1038/ni.2638
  19. O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregu- lation and immune-mediated disease. Immunity. 2012;36:542-550. doi: 10.1016/j.immuni.2012.03.014
  20. Mihrshahi R, Barclay AN, Brown MH. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J Immunol. 2009;183:4879-4886. doi: 10.4049/jimmunol.0901531
  21. Stump KL, Lu LD, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Ator MA, Dorsey BD, et al. A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis. Arthritis Res Ther. 2011;13:R68. doi: 10.1186/ar3329
  22. Tabas I. Macrophage death and defective inflammation resolution in athero- sclerosis. Nat Rev Immunol. 2010;10:36-46. doi: 10.1038/nri2675
  23. Lim HY, Lim SY, Tan CK, Thiam CH, Goh CC, Carbajo D, Chew SHS, See P, Chakarov S, Wang XN, et al. Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regu- lation of smooth muscle cell collagen. Immunity. 2018;49:1191. doi: 10.1016/j.immuni.2018.12.009
  24. Robbins CS, Chudnovskiy A, Rauch PJ, Figueiredo JL, Iwamoto Y, Gorbatov R, Etzrodt M, Weber GF, Ueno T, van Rooijen N, et al. Extra- medullary hematopoiesis generates Ly-6C(high) monocytes that infil- trate atherosclerotic lesions. Circulation. 2012;125:364-374. doi: 10.1161/CIRCULATIONAHA.111.061986
  25. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 2007;317:666-670. doi: 10.1126/science.1142883
  26. Murphy AJ, Tall AR. Disordered haematopoiesis and athero-thrombosis. Eur Heart J. 2016;37:1113-1121. doi: 10.1093/eurheartj/ehv718
  27. Coppin E, De Grandis M, Pandolfi PP, Arcangeli ML, Aurrand-Lions M, Nunès JA. Dok1 and Dok2 proteins regulate cell cycle in hematopoi- etic stem and progenitor cells. J Immunol. 2016;196:4110-4121. doi: 10.4049/jimmunol.1501037
  28. Rijkers ES, de Ruiter T, Buitenhuis M, Veninga H, Hoek RM, Meyaard L. Liga- tion of CD200R by CD200 is not required for normal murine myelopoiesis. Eur J Haematol. 2007;79:410-416. doi: 10.1111/j.1600-0609.2007.00920.x
  29. Griseri T, McKenzie BS, Schiering C, Powrie F. Dysregulated hemato- poietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity. 2012;37:1116-1129. doi: 10.1016/j.immuni.2012.08.025
  30. Anzai A, Choi JL, He S, Fenn AM, Nairz M, Rattik S, McAlpine CS, Mindur JE, Chan CT, Iwamoto Y, et al. The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes. J Exp Med. 2017;214:3293-3310. doi: 10.1084/jem.20170689
  31. Delneste Y, Charbonnier P, Herbault N, Magistrelli G, Caron G, Bonnefoy JY, Jeannin P. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood. 2003;101:143-150. doi: 10.1182/blood-2002-04-1164
  32. de Bruin AM, Libregts SF, Valkhof M, Boon L, Touw IP, Nolte MA. IFNγ induces monopoiesis and inhibits neutrophil development during inflamma- tion. Blood. 2012;119:1543-1554. doi: 10.1182/blood-2011-07-367706
  33. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415-1421. doi: 10.1126/science.8197455
  34. Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111-121. doi: 10.1056/NEJMoa1701719
  35. Desai HR, Sivasubramaniyam T, Revelo XS, Schroer SA, Luk CT, Rikkala PR, Metherel AH, Dodington DW, Park YJ, Kim MJ, et al. Macrophage JAK2 deficiency protects against high-fat diet-induced inflammation. Sci Rep. 2017;7:7653. doi: 10.1038/s41598-017-07923-0
  36. Akkaya M, Aknin ML, Akkaya B, Barclay AN. Dissection of agonistic and blocking effects of CD200 receptor antibodies. PLoS One. 2013;8:e63325. doi: 10.1371/journal.pone.0063325
  37. Amir el-AD, Davis KL, Tadmor MD, Simonds EF, Levine JH, Bendall SC, Shenfeld DK, Krishnaswamy S, Nolan GP, Pe'er D. viSNE enables visu- alization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol. 2013;31:545-552. doi: 10.1038/nbt.2594
  38. Finck R, Simonds EF, Jager A, Krishnaswamy S, Sachs K, Fantl W, Pe'er D, Nolan GP, Bendall SC. Normalization of mass cytometry data with bead standards. Cytometry A. 2013;83:483-494. doi: 10.1002/cyto.a.22271
  39. Fread KI, Strickland WD, Nolan GP, Zunder ER. An updated debarcoding tool for mass cytometry with cell type-specific and cell sample-specific stringency adjustment. Pac Symp Biocomput. 2017;22:588-598. doi: 10.1142/9789813207813_0054
  40. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606. doi: 10.1016/s0002-9149(83)80105-2
  41. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, et al. American college of cardi- ology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478-1492. doi: 10.1016/s0735-1097(01)01175-5
  42. Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B, Cheshire N, Paleolog E, Feldmann M. Canonical pathway of nuclear fac- tor kappa B activation selectively regulates proinflammatory and pro- thrombotic responses in human atherosclerosis. Proc Natl Acad Sci USA. 2004;101:5634-5639. doi: 10.1073/pnas.0401060101
  43. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radio- frequency data analysis. Circulation. 2002;106:2200-2206. doi: 10.1161/01.cir.0000035654.18341.5e
  44. Sinning C, Lillpopp L, Appelbaum S, Ojeda F, Zeller T, Schnabel R, Lubos E, Jagodzinski A, Keller T, Munzel T, et al. Angiographic score assess- ment improves cardiovascular risk prediction: the clinical value of SYN- TAX and Gensini application. Clin Res Cardiol. 2013;102:495-503. doi: 10.1007/s00392-013-0555-4
  45. Downloaded from http://ahajournals.org by on December 19, 2021